Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 20, 2010Antimicrobial Agents and ChemotherapyOpen Access

Activity of a New Cephalosporin, CXA-101 (FR264205), against β-Lactam-Resistant Pseudomonas aeruginosa Mutants Selected In Vitro and after Antipseudomonal Treatment of Intensive Care Unit Patients

View Full Paper
Ask AI
Bookmark
Share

Authors

BMBartolomé MoyáHealth Research Institute of the Balearic IslandsLZLaura ZamoranoInstituto de Salud Carlos IIICJCarlos JuanInstituto de Salud Carlos III

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Moyá et al. (2010) studied this question.

synapsesocial.com/papers/69d8342bf4e559c61eae2d4dhttps://doi.org/10.1128/aac.01104-09
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Activity of a New Antipseudomonal Cephalosporin, CXA-101 (FR264205), against Carbapenem-Resistant and Multidrug-Resistant Pseudomonas aeruginosa Clinical Strains2009 · 99 citations
  2. 2Molecular Epidemiology and Mechanisms of Carbapenem Resistance in Pseudomonas aeruginosa Isolates from Spanish Hospitals2007 · 183 citations
  3. 3The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection1998 · 688 citations
  4. 4Emergence of Antibiotic-Resistant Pseudomonas aeruginosa : Comparison of Risks Associated with Different Antipseudomonal Agents1999 · 543 citations
  5. 5Nosocomial Outbreak of a Non-Cefepime-Susceptible Ceftazidime-Susceptible Pseudomonas aeruginosa Strain Overexpressing MexXY-OprM and Producing an Integron-Borne PSE-1 ß-Lactamase2009 · 34 citations